AstraZeneca Partners with Guangzhou Institute to Advance Respiratory Medicine Research
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced a partnership with China’s Guangzhou Institute...
Company
Indonesia and China Deepen Healthcare Ties with High-Level Dialogue and New Agreements
Indonesia’s deputy minister of health, Dante Saksono Harbuwono, visited China last week as part of...
TYK Medicines Secures FDA Approval for Next-Generation TKI Clinical Trial
China-based TYK Medicines, Inc. has announced that it has received clinical trial approval from the...
Sequanta Technologies Partners with Element Biosciences to Expand Single-Cell Applications
Shanghai-based Sequanta Technologies, a leading multi-omics research and clinical service provider, has announced a strategic...
Yifan Pharmaceutical Receives NMPA Approval for Hyruan ONE in Knee Osteoarthritis Treatment
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) has announced receiving market approval from the National...
Junshi Biosciences Challenges Alynlam’s PCSK9 siRNA Patent with CNIPA
Junshi Biosciences (SHA: 688180) is reportedly taking steps to challenge a key patent held by...
ApolloBio Partners with Baidu Health to Enhance Marketing of IgM Nano Immunoglobulin Spray
Guangzhou-based biotech ApolloBio has signed a strategic cooperation agreement with Baidu Health. Under this partnership,...
Yantai Dongcheng Pharmaceutical Gets Singapore Regulatory Approval for 177Lu-LNC1004 Phase I Study
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving the green light...
AcoStream Second-Generation Receives NMPA Marketing Approval for Peripheral Vascular Use
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
Shenzhen Kangtai Biological Partners with Biotis for 13-Valent Pneumococcal Vaccine in Indonesia
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has struck a partnership with Indonesian...
Harbour BioMed and AstraZeneca Partner to Advance Pharmaceutical Innovation in Yangtze River Delta
Harbour BioMed (HKG: 2142), a biotech with operations in the United States, the Netherlands, and...
Shuwen Biotech’s Subsidiary Signs Promotion Agreement with Sysmex Europe for Breast Cancer Detection Product
China-based diagnostic specialist Shuwen Biotech Co., Ltd announced that its wholly-owned German subsidiary, Cerca Biotech...
Vcanbio Receives CDE Approval for VUM02 Clinical Trial in Idiopathic Pulmonary Fibrosis
China-based Vcanbio Cell & Gene Engineering Corp., Ltd (SHA: 600645) has announced receiving clinical trial...
Luye Pharma Group Partners with Duopharma for Exclusive Marketing Rights of TCM in Malaysia
China-based Luye Pharma Group (HKG: 2186) has signed an agreement with Malaysia’s Duopharma Marketing Sdn...
Scorpion Therapeutics and Pierre Fabre Collaborate on NSCLC Therapies STX-721 and STX-241
US-based Scorpion Therapeutics Inc. has formed a collaboration and license deal with France-based Pierre Fabre,...
Sanofi Partners with Shenzhen’s Pingshan District to Boost Innovative Vaccines in China
French pharmaceutical major Sanofi (NASDAQ: SNY) has signed a partnership agreement with the Pingshan district...
Haisco Pharmaceutical Gets CDE Approval for HSK38008 Prostate Cancer Clinical Study
Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced receiving approval from the Center for...
Yiling Pharmaceutical’s G201-Na Receives CDE Approval for Phase Ia Study in Prostate Cancer Treatment
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced receiving approval from the Center for...
Mabwell’s 9MW2821 ADC Shows Positive Signals in Solid Tumor Clinical Data
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced preliminary clinical data for its...
Gates Foundation and NSFC Launch Partnership to Boost Regulatory Science in Vaccine Development
The Bill & Melinda Gates Foundation (Gates Foundation) and the National Natural Science Foundation of...